S. 4189
119th Congress
Senate
INSULIN Act of 2026
Official title: A bill to reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
Health
Administrative remediesCivil actions and liabilityCompetition and antitrustCongressional oversight
More subjectsShow fewer subjects
Digestive and metabolic diseasesDrug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingPrescription drugs
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 7, 2026
Placed on Senate Legislative Calendar under General Orders. Calendar No. 552.
Aug 7, 2026
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
Jul 22, 2026
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Mar 25, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 25, 2026
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 552.
Related & companion bills
1
Bill text
2 versions
- Introduced in Senate Formatted Text PDF Formatted XML
- Reported to Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Lobbying activity
36
- MASON CONSULTING, LLC
- ALLIANCE DEFENDING FREEDOM
- BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.
- AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
- BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- Centers For Medicare and Medicaid Services (CMS)
- Labor, Dept of (DOL)
- Office of Management & Budget (OMB)
- Executive Office of the President (EOP)
- White House Office
Cosponsors
28
D
Warner, Mark R.
R
McCormick, David
D
Slotkin, Elissa
R
Banks, Jim
D
Booker, Cory A.
D
Cortez Masto, Catherine
R
Hyde-Smith, Cindy
D
Alsobrooks, Angela D.
R
Cramer, Kevin
R
Ernst, Joni
D
Hickenlooper, John W.
D
Blunt Rochester, Lisa
R
Justice, James C.
R
Capito, Shelley Moore
D
Kaine, Tim
D
Coons, Christopher A.
R
Wicker, Roger F.
D
Baldwin, Tammy
R
Britt, Katie Boyd
R
Collins, Susan M.
R
Grassley, Chuck
D
Kelly, Mark
R
Kennedy, John
I
King, Angus S., Jr.
R
Murkowski, Lisa
D
Rosen, Jacky
R
Tuberville, Tommy
D
Warnock, Raphael G.
Cite this page
U.S. Congress. (2026). S. 4189: INSULIN Act of 2026. 119th Congress. Open America. https://openamerica.io/bill/119-S-4189/
"S. 4189: INSULIN Act of 2026." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-4189/.
S. 4189, 119th Cong. (2026), https://openamerica.io/bill/119-S-4189/.
[S. 4189: INSULIN Act of 2026](https://openamerica.io/bill/119-S-4189/)